BiOptix Diagnostics Secures $6,228,202 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=783f887e-8007-48de-9ad9-6f97017a59d7&Preview=1
Date
3/14/2013
Company Name
BiOptix Diagnostics
Mailing Address
1775 38th St. Boulder, CO 80301
Company Description
The company’s mission is to develop its proprietary E-SPR (Enhanced Surface Plasmon Resonance) technology platform for the detection of molecular interactions.
Website
http://www.bioptix.com
Transaction Type
Venture Equity
Transaction Amount
$6,228,202
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed